
Jaroslaw P Maciejewski MD
Professor of Medicine, Case West Res University
Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Dr. Maciejewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1998 - 2000
University of Nevada Reno School of MedicineResidency, Internal Medicine, 1995 - 1998
Humboldt University of Berlin - Charite Faculty of MedicineClass of 1990
Certifications & Licensure
OH State Medical License 2001 - 2026
DC State Medical License 2000 - 2002
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
Clinical Trials
- Identifying Characteristics of Bone Marrow Failure Syndromes Start of enrollment: 2006 Apr 01
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia Start of enrollment: 2006 May 01
- A Phase 2 Study of R115777 in Large Granular Lymphocyte (LGL) Leukemia Start of enrollment: 2006 May 01
Publications & Presentations
PubMed
- Switching patients with PNH from pegcetacoplan to iptacopan: a case series.Mark Orland, Carmelo Gurnari, Srinivasa Sanikommu, Jaroslaw Maciejewski, David Dingli
Hematology. 2026-12-01 - PTCy or ATG for Matched Transplantation in Myelofibrosis.Patrizia Chiusolo, Andrea Bacigalupo, Rachel Salit, Thomas Schroeder, Maria Chiara Finazzi
American Journal of Hematology. 2026-06-01 - Validation of ICC hierarchical classification in secondary AML.Enrico Attardi, Marta Cipriani, Luca Guarnera, Arianna Savi, Emiliano Fabiani
Blood Advances. 2026-05-26
Journal Articles
- Germline Loss of Function SAMD9 and SAMD9L Alterations in Adult Myelodysplastic SyndromesSamuel Li, Mikkael A Sekeres, Jaroslaw P Maciejewski, Rabi Hanna, Blood
- Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
Abstracts/Posters
- Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-AzacytidineJaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant AbstractJaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell TransplantationJaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
Weight-Loss Drugs May Have Surprising Side Effect: Stalling CancerMay 21st, 2026
Cleveland Clinic’s Hemato-Oncology Team Spearheads the Development of Guidelines for Genomic Profiling of MDS to Inform Allo-HCTJune 10th, 2025
Beta-Thalassemia Gene Tx Gets Ringing Endorsement from FDA AdvisersJune 10th, 2022
Grant Support
- Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid LeukemiaCLEVELAND CLINIC LERNER COM-CWRU2025–2030
- Investigating the Role of VISTA in Driving Immune Evasion in Acute Myeloid LeukemiaCLEVELAND CLINIC LERNER COM-CWRU2025–2030
- Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem CellsCLEVELAND CLINIC LERNER COM-CWRU2022–2027
- Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem CellsCLEVELAND CLINIC LERNER COM-CWRU2022–2027
- Targeting TET DNA Dioxygenases as Therapeutic Principle in Myeloid NeoplasmsCLEVELAND CLINIC LERNER COM-CWRU2021–2026
Other Languages
- German, Polish, Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









